Publicaciones en colaboración con investigadores/as de Hospital de Sabadell (56)

2024

  1. Spanish cardiac catheterization and coronary intervention registry. 33rd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2023)

    Revista Espanola de Cardiologia, Vol. 77, Núm. 11, pp. 936-946

2023

  1. Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study

    Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193

  2. Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry

    Journal of Headache and Pain, Vol. 24, Núm. 1

2022

  1. Neuroblastoma in Spain: Linking the national clinical database and epidemiological registries – A study by the Joint Action on Rare Cancers

    Cancer Epidemiology, Vol. 78

  2. Treatment Failure in Axial Spondyloarthritis: Insights for a Standardized Definition

    Advances in Therapy, Vol. 39, Núm. 4, pp. 1490-1501

  3. Use of failure-to-rescue after emergency surgery as a dynamic indicator of hospital resilience during the COVID-19 pandemic. A multicenter retrospective propensity score-matched cohort study

    International Journal of Surgery, Vol. 106

2021

  1. Analysis of outcomes of emergency general and gastrointestinal surgery during the COVID-19 pandemic

    The British journal of surgery, Vol. 108, Núm. 12, pp. 1438-1447

  2. Differences in epidemiology and mortality between men and women with HIV infection in the CoRIS cohort from 2004 to 2014

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 8, pp. 372-382

  3. Incidence, clinical characteristics and management of inflammatory bowel disease in spain: Large-scale epidemiological study

    Journal of Clinical Medicine, Vol. 10, Núm. 13

  4. P-POSSUM as mortality predictor in COVID-19-infected patients submitted to emergency digestive surgery. A retrospective cohort study

    International Journal of Surgery, Vol. 96

  5. Pharmacogenetics of trough serum anti-TNF levels in paediatric inflammatory bowel disease

    British Journal of Clinical Pharmacology, Vol. 87, Núm. 2, pp. 447-457

  6. Predictive value of prolactin in first episode psychosis at ten years follow-up

    Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 3, pp. 179-180

  7. Whole transcription profile of responders to anti-tnf drugs in pediatric inflammatory bowel disease

    Pharmaceutics, Vol. 13, Núm. 1, pp. 1-17

2020

  1. Bismuth quadruple regimen with tetracycline or doxycycline versus three-in-one single capsule as third-line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp-EuReg)

    Helicobacter, Vol. 25, Núm. 5

  2. Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients with Inflammatory Bowel Disease: Results from the Eneida Registry

    Inflammatory Bowel Diseases, Vol. 26, Núm. 4, pp. 606-616

  3. Gene signatures of early response to anti-TNF drugs in pediatric inflammatory bowel disease

    International Journal of Molecular Sciences, Vol. 21, Núm. 9

  4. Predictive value of carcinoembryonic antigen in symptomatic patients without colorectal cancer: A post-hoc analysis within the colonpredict cohort

    Diagnostics, Vol. 10, Núm. 12

  5. Retrospective cohort study: Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test

    World Journal of Gastroenterology, Vol. 26, Núm. 1, pp. 70-85

2018

  1. Improved empirical antibiotic treatment of sepsis after an educational intervention: The ABISS-Edusepsis study

    Critical Care, Vol. 22, Núm. 1

2017

  1. Accuracy of the Ultra-Rapid Urease Test for diagnosis of Helicobacter pylori infection

    Gastroenterologia y Hepatologia, Vol. 40, Núm. 10, pp. 651-657